Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments.

The Mayor of London has launched a new nightlife taskforce which will be led by fabric nightclub founder Cameron Leslie - it will be advising on the future of nightlife in the capital ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

European markets are expected to open in negative territory on Wednesday, with investors looking ahead to more earnings from ...

ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and olde ...

The TAM AdEx 2024 report reveals a mixed performance in television advertising, with a 14 per cent increase from 2020 but a ...

Television ad volumes increased from 7,188 seconds per day in 2020 to 8,210 seconds in 2024, with FMCG accounting for 45% of ...

GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...